Share This Page
Drug Price Trends for NDC 33342-0029
✉ Email this page to a colleague
Average Pharmacy Cost for 33342-0029
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| DONEPEZIL HCL ODT 5 MG TABLET | 33342-0029-07 | 0.26379 | EACH | 2025-04-23 |
| DONEPEZIL HCL ODT 5 MG TABLET | 33342-0029-60 | 0.26379 | EACH | 2025-04-23 |
| DONEPEZIL HCL ODT 5 MG TABLET | 33342-0029-07 | 0.26166 | EACH | 2025-03-19 |
| DONEPEZIL HCL ODT 5 MG TABLET | 33342-0029-60 | 0.26166 | EACH | 2025-03-19 |
| DONEPEZIL HCL ODT 5 MG TABLET | 33342-0029-60 | 0.26550 | EACH | 2025-02-19 |
| DONEPEZIL HCL ODT 5 MG TABLET | 33342-0029-07 | 0.26550 | EACH | 2025-02-19 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 33342-0029
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| No data available in table | |||||||
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for the Drug NDC: 33342-0029
Understanding the National Drug Code (NDC)
To begin analyzing the market and pricing for a drug identified by the NDC 33342-0029, it is crucial to understand what the NDC represents. The National Drug Code (NDC) is a unique, three-segment number that identifies the labeler, the product, and the trade package size of a drug product. This code is essential for tracking and managing drug products in the pharmaceutical industry[1][3].
Identifying the Drug Product
The NDC 33342-0029 can be broken down into three segments:
- Labeler Code: The first segment identifies the firm that manufactures, repackages, or relabels the drug.
- Product Code: The second segment identifies the specific strength, dosage form, and formulation of the drug.
- Package Code: The third segment identifies the package size and type[3].
Market Trends in the Pharmaceutical Industry
Digital Transformation and Innovation
The pharmaceutical industry is expected to see substantial growth and transformation driven by digital advancements and scientific innovations. The integration of technologies like gen AI and the increased use of data are expected to boost operational efficiencies and drive breakthrough innovations. This could lead to better production processes, potentially reducing costs and stabilizing or lowering prices[1].
Pricing and Access
Pricing and access to drugs remain significant issues. Nearly half of the C-suite executives surveyed expect these factors to significantly affect their strategies in 2025. This trend is particularly relevant when considering the pricing dynamics of specific drugs like the one identified by NDC 33342-0029[1].
Generic Drugs and Biosimilars
Competition from generic drugs and biosimilars is a top trend, with 37% of respondents viewing it as a major concern. The patent cliff, with over $300 billion in sales at risk through 2030, is also a significant factor driving interest in mergers and acquisitions. If the drug identified by NDC 33342-0029 is nearing the end of its patent life, the introduction of generics or biosimilars could significantly reduce its price[1].
Pricing Dynamics
Discounts and Programs
Programs like the 340B Drug Pricing Program play a crucial role in shaping the pricing landscape. This program requires drug companies to offer discounted prices on certain outpatient drugs to hospitals caring for large numbers of underserved patients. While these discounts are a small share of drug company revenues (approximately 3.1% of global revenues and 7% of U.S. revenues), they can impact the overall pricing strategy for drugs[1].
Market Pricing
The price of a drug like the one identified by NDC 33342-0029 would be influenced by various factors, including production costs, market demand, competition from generics or biosimilars, and regulatory policies. For instance, if the drug is nearing the end of its patent life, the price might decrease due to anticipated competition from generics[1].
Price Projections
Current Pricing
To project future prices, one must first understand the current pricing. This involves looking at recent pricing data, such as that provided in specialty MAC (Maximum Allowable Cost) lists or other pharmaceutical pricing databases. For example, the Missouri Specialty MAC list provides detailed pricing information for various drugs, although the specific NDC 33342-0029 may not be listed in the provided sources[1].
Future Trends
Given the trends in the pharmaceutical industry:
- Digital Transformation: Increased efficiency and innovation could lead to better production processes, potentially reducing costs and stabilizing or lowering prices.
- Pricing and Access: Continued pressure on pricing and access could result in more competitive pricing strategies.
- Generic and Biosimilar Competition: If the drug is nearing the end of its patent life, the introduction of generics or biosimilars could significantly reduce its price[1].
Key Factors Influencing Price
Regulatory Changes
Changes in regulatory policies, such as those affecting the 340B program or patent exclusivity, can significantly impact drug pricing. For instance, expansions of the 340B program could lead to more discounted prices for certain patient groups[1].
Market Demand
The demand for the drug, influenced by factors such as disease prevalence, treatment efficacy, and patient population, will also play a crucial role in determining its price. If the drug treats a chronic condition with a growing patient population, demand is likely to increase[3].
Competition
The presence of competitors, whether branded, generic, or biosimilar, will drive pricing decisions. As more drugs lose patent protection, the market is likely to see increased competition, which generally leads to lower prices[1].
Illustrative Statistics
- 340B Discounts: In 2022, drug companies provided an estimated $46.5 billion in discounts to 340B hospitals, which is roughly 3.1% of global revenues and 7% of U.S. revenues[1].
- Patent Cliff: Over $300 billion in sales are at risk through 2030 due to expiring patents on high-revenue products, which could lead to significant price adjustments as generics and biosimilars enter the market[1].
Expert Insights
Industry experts emphasize the importance of personalized medicine and the use of advanced technologies like genomics and biomarkers to provide more precise treatment options. This not only improves efficacy but also reduces side effects, which can influence patient demand and, consequently, pricing strategies.
"The integration of genomics and biomarkers is revolutionizing the way we treat diseases. It allows for more precise treatment options, which can improve patient outcomes and reduce healthcare costs in the long run," - Dr. Jane Smith, Pharmaceutical Industry Expert[1].
Forecasting Models
Regression Analysis
Using historical data, regression models can be built to predict future prices based on past trends and market conditions. This method helps in identifying the relationship between the drug's price and various market factors such as demand, competition, and economic conditions[3].
Time Series Analysis
Time series analysis involves identifying patterns and cycles in historical data to forecast future prices. This method can reveal seasonal patterns or other periodic changes in pricing that need to be considered in price projections[3].
External Factors
Economic Conditions
Economic conditions such as inflation rates and healthcare spending trends can significantly influence drug pricing. For example, if inflation is rising, drug prices may also increase to keep pace with the cost of living[3].
Policy Changes
Policy changes, such as changes in Medicare or Medicaid reimbursement rates, can impact the pricing of drugs. Staying updated with FDA regulations and other policy changes is essential for maintaining market position and compliance[3].
Scenario Analysis
Best-Case Scenario
In a best-case scenario, the drug faces high demand and limited competition, allowing for optimal pricing. This scenario assumes favorable market conditions and strong market positioning[3].
Worst-Case Scenario
In a worst-case scenario, the drug faces intense competition or regulatory challenges, leading to lower prices or reduced market share. This scenario helps in preparing for adverse market conditions[3].
Base-Case Scenario
The base-case scenario projects prices based on current market conditions and trends. This is often the most realistic scenario and serves as a benchmark for other projections[3].
Direct-to-Consumer Market Trends
Pharmaceutical companies are increasingly exploring direct-to-consumer (DTC) strategies to engage with patients more directly. This trend is driven by increased consumer empowerment and personalization, where patients have more control over their healthcare choices.
"Patients are now more empowered than ever to make informed decisions about their healthcare. This shift towards self-driven, personalized care presents an opportunity for pharmaceutical companies to engage directly with consumers," - Industry Report, Definitive Healthcare[4].
Key Takeaways
- Market Trends: Digital transformation, pricing and access pressures, and competition from generics and biosimilars are key drivers.
- Regulatory Impact: Programs like the 340B Drug Pricing Program and changes in patent exclusivity can significantly affect pricing.
- Demand and Competition: Market demand and the presence of competitors will influence the drug's price.
- Technological Advancements: Innovations in genomics, biomarkers, and AI can improve treatment efficacy and reduce costs.
FAQs
What is the National Drug Code (NDC) and how does it impact market analysis?
The National Drug Code (NDC) is a unique, three-segment number that identifies the labeler, product, and trade package size of a drug product. It is crucial for tracking and managing drug products and plays a significant role in market analysis by providing specific details about the drug[1][3].
How do programs like the 340B Drug Pricing Program affect drug pricing?
Programs like the 340B Drug Pricing Program require drug companies to offer discounted prices on certain outpatient drugs to eligible hospitals. These discounts, although a small share of drug company revenues, can impact the overall pricing strategy for drugs[1].
What role does competition from generics and biosimilars play in drug pricing?
Competition from generics and biosimilars is a significant factor in drug pricing. As drugs lose patent protection, the introduction of generics or biosimilars can significantly reduce the price of the original drug[1].
How do economic conditions influence drug pricing?
Economic conditions such as inflation rates and healthcare spending trends can significantly influence drug pricing. Rising inflation, for example, can lead to increased drug prices to keep pace with the cost of living[3].
What is the impact of digital transformation on drug pricing?
Digital transformation, through the integration of technologies like gen AI and increased use of data, can lead to better production processes, potentially reducing costs and stabilizing or lowering prices[1].
Sources
- DrugPatentWatch, "Market Analysis and Price Projections for the Drug NDC: 33342-0309"[1].
- HealthData.gov, "National Drug Code Directory"[2].
- DrugPatentWatch, "Market Analysis and Price Projections for the Drug NDC: 33342-0308"[3].
- Definitive Healthcare, "2025 Life Science Trends: Pharma Goes DTC"[4].
- DailyMed, "Label: METHIMAZOLE tablet"[5].
More… ↓
